- Investing Ideas
- /
- U.S. Buy the Dip
U.S. Buy the Dip
UPDATED Apr 24, 2024
Companies which may present a buying opportunity after a dip in share price.
671 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GBT | US$68.49 | 0.6% | 169.5% | US$4.6b | US$68.50 | PS19.7x | E66.2% | n/a | Pharmaceuticals & Biotech | ||
ARCT | US$27.93 | 1.0% | 4.8% | US$751.7m | US$67.89 | PS4.5x | E60.0% | n/a | Pharmaceuticals & Biotech | ||
CREX | US$3.40 | 9.1% | 36.0% | US$35.5m | US$7.13 | PB1.2x | E129.1% | n/a | Media | ||
RPD | US$46.49 | 6.1% | -6.3% | US$2.9b | US$59.95 | PS3.7x | E111.4% | n/a | Software | ||
PWFL | US$4.22 | 4.2% | 54.0% | US$447.2m | US$8.00 | PS3.4x | E102.5% | n/a | Tech | ||
AAOI | US$10.85 | -9.4% | 426.7% | US$432.4m | US$18.00 | PS1.9x | E134.2% | n/a | Tech | ||
PPSI | US$3.68 | 0% | -25.8% | US$37.3m | US$10.50 | PE20.6x | E37.6% | n/a | Capital Goods | ||
HROW | US$10.27 | -13.1% | -58.7% | US$364.9m | US$26.65 | PS2.8x | E67.2% | n/a | Pharmaceuticals & Biotech | ||
CDXC | US$3.40 | -14.4% | 157.6% | US$256.6m | US$6.08 | PS3.1x | E93.2% | n/a | Pharmaceuticals & Biotech | ||
RAMP | US$32.36 | 1.9% | 40.3% | US$2.2b | US$47.75 | PS3.4x | E176.3% | n/a | Software | ||
SGRY | US$25.50 | 4.2% | -35.5% | US$3.2b | US$42.36 | PS1.2x | E46.3% | n/a | Healthcare | ||
EXPI | US$10.34 | 6.1% | -6.6% | US$1.6b | US$12.67 | PB6.5x | E120.2% | 1.9% | Real Estate Management and Development | ||
PCRX | US$25.90 | -3.2% | -41.2% | US$1.2b | US$45.73 | PE28.7x | E29.3% | n/a | Pharmaceuticals & Biotech | ||
AMPH | US$41.00 | 2.4% | 7.4% | US$2.0b | US$62.60 | PE14.6x | E19.7% | n/a | Pharmaceuticals & Biotech | ||
ARRY | US$12.23 | 9.5% | -39.8% | US$1.8b | US$20.22 | PE21.7x | E21.7% | n/a | Capital Goods | ||
XP | US$20.64 | -4.3% | 55.1% | US$11.3b | US$29.33 | PE14.9x | E16.0% | 6.8% | Diversified Financials | ||
TLRY | US$1.84 | 7.0% | -15.6% | US$1.4b | US$2.37 | PS1.9x | E86.1% | n/a | Pharmaceuticals & Biotech | ||
PGY | US$9.41 | -9.0% | -12.9% | US$651.2m | US$38.00 | PB1.2x | E129.5% | n/a | Software | ||
VRME | US$1.65 | 3.8% | 3.1% | US$15.7m | US$2.85 | PB1.3x | E70.2% | n/a | Tech | ||
ICPT | US$19.00 | 0.1% | 19.1% | US$794.7m | US$19.00 | PS2.5x | E42.4% | n/a | Pharmaceuticals & Biotech | ||
TWI | US$11.80 | 3.1% | 24.7% | US$715.0m | US$19.00 | PE9.1x | E24.2% | 0% | Capital Goods | ||
YSG | US$4.24 | 17.5% | -1.1% | US$423.3m | US$4.35 | PB0.8x | E120.5% | n/a | Household | ||
AUNA | US$7.55 | 0.7% | n/a | US$506.3m | US$15.86 | PB1.4x | E44.7% | n/a | Healthcare | ||
IBTX | US$40.82 | 3.2% | 11.4% | US$1.7b | US$48.14 | PB0.7x | E28.5% | 3.7% | Banks |